日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tamoxifen induces PI3K activation in uterine cancer.

他莫昔芬可诱导子宫癌细胞中PI3K活化。

Kübler Kirsten, Nardone Agostina, Anand Shankara, Gurevich Daniel, Gao Jianjiong, Droog Marjolein, Hermida-Prado Francisco, Akhshi Tara, Feiglin Ariel, Feit Avery S, Cohen Feit Gabriella, Dackus Gwen, Pun Matthew, Kuang Yanan, Cha Justin, Miller Mendy, Gregoricchio Sebastian, Lanfermeijer Mirthe, Cornelissen Sten, Gibson William J, Paweletz Cloud P, Van Allen Eliezer M, van Leeuwen Flora E, Nederlof Petra M, Nguyen Quang-Dé, Mourits Marian J E, Radovich Milan, Leshchiner Ignaty, Stewart Chip, Matulonis Ursula A, Zwart Wilbert, Maruvka Yosef E, Getz Gad, Jeselsohn Rinath

Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial

来曲唑、阿贝西利和二甲双胍治疗子宫内膜癌:一项非随机 II 期试验

Konstantinopoulos, Panagiotis A; Zhou, Ningxuan; Penson, Richard T; Le, Tien V; Campos, Susana; Krasner, Carolyn; Wright, Alexi A; Porter, Rebecca; Horowitz, Neil; Bouberhan, Sara; Liu, Joyce F; Hindenach, Sarah; Sawyer, Hannah; Koppermann, Lani; Hayes, Martin; Polak, Madeline; Shea, Meghan; Widick, Page; Cheng, Su-Chun; Castro, Cesar; Beumer, Jan H; Matulonis, Ursula A; Lee, Elizabeth K

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S

Smartphone-Based Measures as Indicators of Functional Status in Patients With Advanced Cancer

基于智能手机的测量方法作为晚期癌症患者功能状态的指标

Straczkiewicz, Marcin; Keating, Nancy L; Schonholz, Stephanie M; Matulonis, Ursula A; Horowitz, Neil; Campos, Susana; Onnela, Jukka-Pekka; Wright, Alexi A

Ovarian Sex Cord Tumor With Annular Tubules (SCTAT) Harbor Recurrent Copy Number Alterations, Including Monosomy 22

卵巢性索肿瘤伴环状小管(SCTAT)存在复发性拷贝数改变,包括22号染色体单体

Leader, Andrew M; Neil, Alexander; Siegmund, Stephanie; Dehghani, Amir; Ligon, Azra; Matulonis, Ursula A; Nucci, Marisa R; McCluggage, W Glenn; Howitt, Brooke E; Kolin, David L

Diagnostic and therapeutic advances for HER2-expressing or amplified gynecologic cancers

HER2表达或扩增的妇科癌症的诊断和治疗进展

Lee, Elizabeth K; Kolin, David L; Matulonis, Ursula A; Erickson, Britt K

The pervasive impact of frailty on ovarian cancer care and the role of prehabilitation: Qualitative perspectives of key stakeholders

虚弱对卵巢癌治疗的普遍影响及术前康复的作用:主要利益相关者的定性视角

Cham, Stephanie; Pozzar, Rachel A; Horowitz, Neil; Feltmate, Colleen; Matulonis, Ursula A; Lai, Jennifer C; Wright, Alexi A

Usability, Acceptability, and Barriers to Implementation of a Collaborative Agenda-Setting Intervention (CASI) to Promote Person-Centered Ovarian Cancer Care: Development Study

协作式议程设置干预措施(CASI)在促进以人为本的卵巢癌护理方面的可用性、可接受性和实施障碍:开发研究

Pozzar, Rachel A; Tulsky, James A; Berry, Donna L; Batista, Jeidy; Barwick, Paige; Lindvall, Charlotta J; Dykes, Patricia C; Manni, Michael; Matulonis, Ursula A; McCleary, Nadine J; Wright, Alexi A

Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma

p53 和 RB 细胞周期调控功能分析提示子宫内膜癌存在机制驱动的分子分层

Zelei Yang # ,Saie Mogre # ,Hyeji Jun ,Ruiyang He ,Sneha Ghosh Chaudhary ,Upendra Raj Bhattarai ,Shannan J Ho Sui ,Ursula A Matulonis ,Suzan Lazo ,Aniket Shetty ,Amy Cameron ,Quang-Dé Nguyen ,Sarah J Hill

Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma

Wee1抑制剂adavosertib治疗复发性子宫癌肉瘤的II期研究

Cham, Stephanie; Xiong, Niya; Tayob, Nabihah; Krasner, Carolyn; Wright, Alexi A; Lee, Elizabeth K; Sawyer, Hannah; Mathews, Cara; Konstantinopoulos, Panagiotis A; Matulonis, Ursula A; Liu, Joyce F